CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Up 506.1% in November

CV Sciences, Inc. (OTCMKTS:CVSIGet Free Report) was the target of a large increase in short interest in November. As of November 15th, there was short interest totalling 59,400 shares, an increase of 506.1% from the October 31st total of 9,800 shares. Based on an average daily volume of 484,300 shares, the short-interest ratio is presently 0.1 days.

CV Sciences Price Performance

Shares of CVSI opened at $0.04 on Thursday. CV Sciences has a one year low of $0.03 and a one year high of $0.10. The business has a fifty day moving average of $0.05 and a 200 day moving average of $0.05. The firm has a market capitalization of $7.37 million, a P/E ratio of -3.99 and a beta of 0.59.

CV Sciences Company Profile

(Get Free Report)

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.

Featured Stories

Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.